Massachusetts Financial Services’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,737
Closed -$206K 923
2024
Q4
$206K Buy
+5,737
New +$215K ﹤0.01% 868
2020
Q1
Sell
-6,139
Closed -$482K 841
2019
Q4
$482K Sell
6,139
-662
-10% -$48.8K ﹤0.01% 782
2019
Q3
$465K Buy
6,801
+759
+13% +$51K ﹤0.01% 797
2019
Q2
$480K Buy
6,042
+842
+16% +$66.8K ﹤0.01% 815
2019
Q1
$436K Buy
+5,200
New +$543K ﹤0.01% 817
2016
Q1
Sell
-9,702
Closed -$620K 877
2015
Q4
$620K Buy
9,702
+732
+8% +$47.5K ﹤0.01% 775
2015
Q3
$601K Buy
+8,970
New +$634K ﹤0.01% 796
2014
Q4
Sell
-20,974
Closed -$772K 909
2014
Q3
$772K Sell
20,974
-576
-3% -$20.8K ﹤0.01% 804
2014
Q2
$842K Sell
21,550
-550
-2% -$20.4K ﹤0.01% 800
2014
Q1
$833K Buy
+22,100
New +$772K ﹤0.01% 779

Other funds holding USNA

Massachusetts Financial Services's USNA Position: Q1 2025 in Review

Massachusetts Financial Services sold out of Usana Health Sciences (USNA) in Q1 2025, closing a stake of 5,737 shares — an estimated $206K sold.

Massachusetts Financial Services first reported a position in USNA in Q1 2014 and held it in 10 quarters. The position peaked at $842K in Q2 2014. 162 funds tracked by Wall St. Rank hold USNA as of Q1 2025.

  • Massachusetts Financial Services reported no remaining Usana Health Sciences position as of Q1 2025 after selling out during the quarter.
  • Massachusetts Financial Services sold 5,737 Usana Health Sciences shares in Q1 2025, an estimated $206K.
  • Massachusetts Financial Services first reported a position in Usana Health Sciences in Q1 2014 and held it in 10 quarters.
  • Massachusetts Financial Services's Usana Health Sciences position peaked at $842K in Q2 2014.
  • 162 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2025.

Based on Massachusetts Financial Services's 13F filing for Q1 2025, filed 2 May 2025.